Skip to main content

Table 4 Mean and SD in baseline, post-treatment and follow up

From: Transdiagnostic treatment of emotional disorders for women with multiple sclerosis: a randomized controlled trial

Measure

Control group (TAU) n = 32

Intervention group (UP) n = 32

Time 1

Time 2

Time 3

Time 1

Time 2

Time 3

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

M (SD)

PANAS-PA

26.72 (3.97)

26.63 (3.74)

27.03 (4.22)

25.28 (3.44)

31.97 (3.59)

34.43 (3.71)

PANAS-NA

27.22 (2.88)

28.06 (2.91)

28.22 (2.67)

27.63 (2.55)

22.00 (2.54)

23.34 (3.22)

PSWQ

46.1 (9.39)

46.50 (8.10)

44.37 (8.49)

49.0 (9.45)

41.38 (9.25)

43.4 (11.18)

HADS-A

12.47 (1.52)

12.06 (1.26)

11.78 (1.66)

13.1 (1.51)

7.25 (1.60)

7.34 (1.78)

HADS-D

12.4 (1.81)

12.90 (1.74)

12.37 (1.80)

12.9 (1.80)

8.12 (2.40)

6.94 (1.76)

DERS

125.1 (17.4)

120.0 (17.43)

125.1 (14.08)

133.0 (15.56)

98.1 (21.94)

93.9 (19.04)